Emergent Biosolutions
(EBS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 105,600 | 111,700 | 642,600 | 576,300 | 621,500 |
| Receivables | 154,500 | 191,000 | 159,200 | 274,700 | 230,900 |
| Inventories | 311,700 | 328,900 | 350,700 | 350,800 | 307,000 |
| TOTAL | $598,700 | $679,500 | $1,210,400 | $1,272,100 | $1,195,900 |
| Non-Current Assets | |||||
| PPE Net | 270,600 | 382,800 | 817,600 | 800,100 | 644,100 |
| Intangibles | 501,500 | 566,600 | 947,000 | 829,500 | 929,800 |
| Other Non-Current Assets | 18,900 | 194,300 | 191,300 | 57,300 | 113,400 |
| TOTAL | $791,000 | $1,143,700 | $1,955,900 | $1,686,900 | $1,687,300 |
| Total Assets | $1,389,700 | $1,823,200 | $3,166,300 | $2,959,000 | $2,883,200 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 413,700 | 957,300 | 31,600 | N/A |
| Accounts payable and accrued liabilities | 60,900 | 112,200 | 103,500 | 128,900 | 136,100 |
| Accrued Expenses | 73,800 | 92,700 | 122,200 | 140,400 | 131,500 |
| Other current liabilities | 27,700 | 32,700 | 45,900 | 72,900 | 116,900 |
| TOTAL | $162,400 | $651,300 | $1,228,900 | $373,800 | $384,500 |
| Non-Current Liabilities | |||||
| Long Term Debt | 663,700 | 446,500 | 448,500 | 809,400 | 841,000 |
| Other Non-Current Liabilities | 39,100 | 28,900 | 41,500 | 61,900 | 157,500 |
| TOTAL | $744,500 | $522,600 | $549,700 | $966,200 | $1,051,700 |
| Total Liabilities | $906,900 | $1,173,900 | $1,778,600 | $1,340,000 | $1,436,200 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 54,337 | 52,203 | 50,140 | 50,501 | 53,300 |
| Common Shares | 100 | 100 | 100 | 100 | 100 |
| Retained earnings | -212,400 | -21,800 | 738,700 | 957,800 | 726,900 |
| Other shareholders' equity | -4,900 | -5,400 | 3,400 | -16,300 | -24,900 |
| TOTAL | $482,800 | $649,300 | $1,387,700 | $1,619,000 | $1,447,000 |
| Total Liabilities And Equity | $1,389,700 | $1,823,200 | $3,166,300 | $2,959,000 | $2,883,200 |